Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) plus Basal Insulin vs. GLP-1RA in Type 2 Diabetes Mellitus-A Systematic Review and Meta-analysis

被引：0
|
作者：
Satti, Muniza M.
O'Brien, Timothy
Liew, Aaron
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1108-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of Glucagon-like peptide-1 receptor agonist (GLP-1RA) plus basal insulin versus basal insulin in Type 2 Diabetes Mellitus: A Systematic review and Meta-analysis
    Conboy, M.
    Houlihan, C.
    O'Brien, T.
    Liew, A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S372 - S372
  • [2] Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population
    Hiep Nguyen
    Robert Dufour
    Amanda Caldwell-Tarr
    Advances in Therapy, 2017, 34 : 658 - 673
  • [3] PATIENT PREFERENCES FOR FREQUENCY OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1RA) INJECTIONS IN THE TREATMENT OF TYPE 2 DIABETES
    Hauber, A. B.
    Nguyen, H.
    Posner, J.
    Ervin, C. M.
    LaRue, S.
    Kalsekar, I
    VALUE IN HEALTH, 2014, 17 (03) : A255 - A255
  • [4] Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population
    Nguyen, Hiep
    Dufour, Robert
    Caldwell-Tarr, Amanda
    ADVANCES IN THERAPY, 2017, 34 (03) : 658 - 673
  • [5] GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1RA) AND UPPER ENDOSCOPY: A REAL WORLD EXPERIENCE
    Siranart, Noppachai
    Thompson, Christopher
    Jirapinyo, Pichamol
    GASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB307 - AB307
  • [6] Adherence to Glucagon-like Peptide-1 Receptor Agonist (GLP-1RA) Therapy in Patients with Type 2 Diabetes Mellitus (T2DM)
    Johnston, Stephen
    Nguyen, Hiep
    Felber, Eugene
    Cappell, Katherine
    Nelson, James K.
    Chu, Bong-Chul
    Kalsekar, Iftekhar
    DIABETES, 2014, 63 : A604 - A604
  • [7] HEALTH CARE COSTS AMONG TYPE 2 DIABETES MELLITUS PATIENTS INITIATING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1RA) THERAPY
    Johnston, S. S.
    Nguyen, H.
    Felber, E.
    Cappell, K.
    Nelson, J.
    Chu, B. C.
    Kalsekar, I
    VALUE IN HEALTH, 2014, 17 (03) : A244 - A244
  • [8] Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysis
    Lisco, Giuseppe
    De Tullio, Anna
    Disoteo, Olga
    De Geronimo, Vincenzo
    Piazzolla, Giuseppina
    De Pergola, Giovanni
    Giagulli, Vito Angelo
    Jirillo, Emilio
    Guastamacchia, Edoardo
    Sabba, Carlo
    Triggiani, Vincenzo
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [9] Effects of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) on Cardiac Structure and Function: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials
    Shi Yin Wong
    Ainsley Ryan Yan Bin Lee
    Aaron Hon Jiun Sia
    Yu Jun Wo
    Yao Hao Teo
    Yao Neng Teo
    Nicholas L. Syn
    Ching-Ching Ong
    Lynette L. Teo
    Tiong-Cheng Yeo
    Kian-Keong Poh
    William K. Kong
    Raymond C. Wong
    Ching-Hui Sia
    Cardiovascular Drugs and Therapy, 2024, 38 : 371 - 389
  • [10] Effects of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) on Cardiac Structure and Function: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials
    Wong, Shi Yin
    Lee, Ainsley Ryan Yan Bin
    Sia, Aaron Hon Jiun
    Wo, Yu Jun
    Teo, Yao Hao
    Teo, Yao Neng
    Syn, Nicholas L.
    Ong, Ching-Ching
    Teo, Lynette L.
    Yeo, Tiong-Cheng
    Poh, Kian-Keong
    Kong, William K.
    Wong, Raymond C.
    Sia, Ching-Hui
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (02) : 371 - 389
12345